Columbia researchers develop first fully organic bioelectronic device

FHS
July 11, 2023
2:40 am

As researchers make major advances in medical care, they are also discovering that the efficacy of these treatments can be enhanced by individualized approaches.

MR-139 by Viatris for Blepharitis: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

July 4, 2024

FTC Sues Anesthesia Group and Its Private Equity Backers

For the first time in history, the Federal Trade Commission (FTC) has sued both a medical group and its private equity backers, alleging anticompetitive practices

September 27, 2023

Opinion | Xylazine: New Drug, Same Old Mistakes

Marino is a medical toxicologist, addiction medicine specialist, and emergency physician. Reports of the drug xylazine being detected in overdoses across the U.S. have been

July 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.